The 7th International Conference on Head and Neck Cancer
The 7th International Conference on Head and Neck Cancer
批准号:
7486677
负责人:
Jeffrey Nicholas Myers
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-02 至 2009-04-30
关键词:
AmericanAmerican Society of Clinical OncologyAreaChemopreventionClinical InvestigatorCommunitiesDentalDeveloped CountriesDeveloping CountriesDevelopmentDiagnostic ImagingDisciplineEnsureEnvironmentFamiliarityFundingFutureHead and Neck CancerHead and Neck SurgeryHead and neck structureImageImmunologistImmunologyInternationalLeadMedical OncologyMental HealthMolecularMolecular GeneticsNurse&aposs RoleNutritionistOncologistOperative Surgical ProceduresOrganOutcomePainParticipantPathogenesisPatientsQuality of lifeRadiation OncologyRadiation therapyRadiology SpecialtyRadiology, Head, NeckRehabilitation therapyReportingResearchResearch PersonnelSan FranciscoScheduleSeriesSocial WorkersSocietiesSpecialistSpeech PathologistStudentsTherapeuticTravelTumor Cell Biologycancer carechemotherapydesignfunctional outcomesgene therapyhead and neck cancer patientmedical specialtiesoncologysymposiumtreatment program
中文摘要
描述(申请人提供):第七届头颈癌国际会议(SICHNCA)是每四年举行一次的系列会议中的下一次。国际会议是最重要的国际跨学科会议,集中在一次会议上,讨论与头颈癌有关的主题。这些主题包括分子遗传学、肿瘤细胞生物学、免疫学、基因治疗、器官保留外科、放射学和成像、放射治疗、化疗、化学预防和生活质量问题。会议旨在促进从业者、受训人员和研究人员之间的讨论,重点是协作、多学科治疗和康复如何能够为头颈癌患者带来最佳的肿瘤学、功能和生活质量结果;2)将临床研究人员、遗传学家、免疫学家和分子和细胞生物学家聚集在一起,分享头颈癌的最新进展,确定未来研究的必要领域,并将这些信息传播给相关领域的更多研究人员。代表医学肿瘤学(美国临床肿瘤学学会)、放射肿瘤学(美国治疗放射肿瘤学学会)、诊断成像(美国头颈部放射学和头颈外科学会)(美国头颈学会)的四个学会的参与将确保专业内部和专业之间的教育互动,从而加强多学科合作关系。项目简介:第七届头颈癌国际会议将于2008年7月19日至23日在加利福尼亚州旧金山举行,旨在促进从业者、受训人员和研究人员之间的讨论,重点是协作、多学科治疗和康复如何为头颈癌患者带来最佳的肿瘤学、功能性和高质量的生活结果。会议的目标包括:1)进一步了解当前环境下的头颈部癌症护理和研究,以及所代表的多个学科内部和之间的研究;2)认识到护士、言语病理学家、听力科医生、营养师、社会工作者、疼痛专家、心理健康从业者、物理治疗师、牙科肿瘤学家在实现最大功能结果和适当的功能评估以及报告新治疗方案的功能结果方面的重要作用;以及3)熟悉新的研究突破,这些突破有助于我们更好地了解头颈部癌症的发病机制和治疗。为了将这一信息尽可能公平地传播给世界各地的头颈肿瘤学从业者,使他们的患者可能从该领域的最新发展中受益,这些资金将用于支持来自世界各地包括发展中国家的学生、居民、研究员和其他参与者的旅费。
英文摘要
DESCRIPTION (provided by applicant): The 7th International Conference on Head and Neck Cancer (SICHNCa) is the next scheduled conference in a series held every four years. The international conferences are the most important international interdisciplinary conferences focused, in a single meeting, on topics related to head and neck cancer. These topics include molecular genetics, tumor cell biology, immunology, gene therapy, organ-sparing surgery, radiology and imaging, radiotherapy, chemotherapy, chemoprevention, and quality of life issues. The conference is designed 1) to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients; 2) to bring together clinical investigators, geneticists, immunologists, and molecular and cellular biologists to share recent advances in head and neck cancer, identify needed areas of future research and disseminate this information to the larger community of investigators in related fields. The participation of four societies representing the disciplines of Medical Oncology (American Society for Clinical Oncology), Radiation Oncology (American Society of Therapeutic Radiation Oncology), Diagnostic Imaging (American Society of Head and Neck Radiology and Head and Neck Surgery (American Head and Neck Society) will ensure educational interaction within and between specialties that can strengthen multi-disciplinary collaborative relationships. Project Narrative: The 7th International Conference on Head and Neck Cancer to be held July 19-23, 2008 in San Francisco, CA is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. Objectives for the meeting include 1) to further understanding in the current environment in head and neck cancer care and research within and between the multiple disciplines represented; 2) to recognize the important role of nurses, speech pathologists, audiologists, nutritionists, social workers, pain specialists, mental health practitioners, physical therapists, dental oncologists in achieving maximal functional outcomes and proper functional assessment and reporting of functional results of new treatments programs, and 3) to provide familiarity with emerging research breakthroughs that are helping us to better understand the pathogenesis and treatment of head and neck cancer. In order for this information to be disseminated as equitably as possible to practitioners of head and neck oncology around the world so that their patients may potentially benefit from the most current developments in the field, these funds will be used to support the travel expenses of students, residents, fellows and other participants from around the world including developing nations.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Accuracy Evaluation of a CE-Marked Glucometer System for Self-Monitoring of Blood Glucose With Three Reagent Lots Following ISO 15197:2013.
使用遵循 ISO 15197:2013 的三个试剂批次进行自我监测血糖的 CE 标记血糖仪系统的准确性评估。
DOI:
10.1177/1932296816670401
发表时间:
2017
期刊:
Journal of diabetes science and technology
影响因子:
5
作者:
[Hehmke,Bernd, Berg,Sabine, Salzsieder,Eckhard]
通讯作者:
Salzsieder,Eckhard
Admin-Core-001
-
批准号:10942944
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2023
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10767096
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Administrative Core
-
批准号:10518174
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
-
批准号:10617289
-
项目类别:
-
资助金额:$55.61万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10830565
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10518173
-
项目类别:
-
资助金额:$123.73万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
-
批准号:10442206
-
项目类别:
-
资助金额:$55.61万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Administrative Core
-
批准号:10707158
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
The Houston Center for Acquired Resistance Research (H-CARR)
-
批准号:10707142
-
项目类别:
-
资助金额:$117.47万
-
财政年份:2022
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9281788
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:8893048
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9433803
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:9067264
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer
-
批准号:8768360
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2014
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression of Metastasis of Oral Tongue Cancer
-
批准号:7214870
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression of Metastasis of Oral Tongue Cancer
-
批准号:7051438
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8232943
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8817640
-
项目类别:
-
资助金额:$49.79万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:8435297
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
Progression and Metastasis of Oral Tongue Cancer
-
批准号:7656535
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2003
-
负责人:Jeffrey Nicholas Myers
-
依托单位:
海外基金